Trial intelligence / Profile preview

Escitalopram for depression in patients with acute coronary artery syndrome

KCT0000053Phase 4Recruiting

Sponsor
Lundbeck
Start
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Lundbeck. Started May 2007; status: recruiting.

02

Drugs

escitalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on KCT0000053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call